Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Irritability: A Post-Hoc Analysis on Symptoms of Anger

被引:0
|
作者
Menard, Francois [1 ]
Davidsen, Charlotte Kampp [1 ]
Weiller, Emmanuelle [1 ]
Baker, Ross A. [1 ]
机构
[1] Otsuka OPDC, Princeton, NJ USA
关键词
Anger; MDD; Irritability; Brexpiprazole;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
M107
引用
收藏
页码:S175 / S176
页数:2
相关论文
共 50 条
  • [31] Pregnenolone in the Treatment of Irritability in Autism Spectrum Disorder: A Post-Hoc Metabolomic Analysis
    Fung, Lawrence
    Sun, Wenchao
    Libove, Robin
    Tanaka, Serena
    Kwa, Lauren
    Philips, Jennifer
    Haddad, Francois
    Rajadas, Jayakumar
    Hardan, Antonio
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S188 - S188
  • [32] EFFECT OF BREXPIPRAZOLE ON ENGAGEMENT IN PATIENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF THREE STUDIES
    Ismail, Zahinoor
    Pedersen, Anne M.
    Thase, Michael E.
    Meehan, Stine Rasmussen
    Weiss, Catherine
    Larsen, Klaus Groes
    Chen, Dalei
    Nylander, Anna-Greta
    Baker, Ross A.
    McIntyre, Roger
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S208 - S209
  • [33] The influence of baseline functioning on life engagement outcomes: post hoc analysis of three brexpiprazole studies in major depressive disorder
    McIntyre, R.
    Wang, F.
    Chen, D.
    Laird, A. De Jong
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S509 - S509
  • [34] Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews
    Catherine Weiss
    Stine R. Meehan
    T. Michelle Brown
    Catherine Gupta
    Michael F. Mørup
    Michael E. Thase
    Roger S. McIntyre
    Zahinoor Ismail
    Journal of Patient-Reported Outcomes, 5
  • [35] Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews
    Weiss, Catherine
    Meehan, Stine R.
    Brown, T. Michelle
    Gupta, Catherine
    Morup, Michael F.
    Thase, Michael E.
    McIntyre, Roger S.
    Ismail, Zahinoor
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2021, 5 (01)
  • [36] Esketamine Nasal Spray for Rapid Reduction of Symptoms of Major Depressive Disorder in Adult Patients at Imminent Risk for Suicide: A Post-Hoc Analysis of North American Subjects
    Nash, Abigail
    Turkoz, Ibrahim
    Fu, Dong-Jing
    Ionescu, Dawn
    Daly, Ella
    Canuso, Carla
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 127 - 127
  • [37] Early versus conventional switching of antidepressant: a post-hoc analysis of clinical trial data for major depressive disorder with moderate to severe pain symptoms
    Pae, Chi-Un
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (18) : 2711 - 2715
  • [38] A Real-life Study of Brexpiprazole as an Adjunctive Treatment for Major Depressive Disorder in Asian Patients in Singapore (BADA)
    Mok, Yee Ming
    Tan, Pei Lin Lynnette
    Bose, Rohini
    Herr, Keira Joann
    Ung, Ken Eng Khean
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (03) : 531 - 536
  • [39] Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study
    Wesnes, Keith A.
    Gommoll, Carl
    Chen, Changzheng
    Sambunaris, Angelo
    McIntyre, Roger S.
    Harvey, Philip D.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (02) : 72 - 79
  • [40] Adjunctive brexpiprazole, a novel effective strategy for treating Major depressive disorder?: Systematic review and Meta-analysis
    Yoon, Seoyoung
    Shin, Cheolmin
    Jeon, Sangwon
    Han, Changsu
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 103 - 103